2020
DOI: 10.1101/2020.10.12.335521
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Codon usage pattern reveals SARS-CoV-2 as a monomorphic pathogen of hybrid origin with role of silent mutations in rapid evolutionary success

Abstract: Viruses are dependent on the host tRNA pool, and an optimum codon usage pattern (CUP) is a driving force in its evolution. Systematic analysis of CUP of replicase (rdrp), spike, envelope (E), membrane glycoprotein (M), and nucleocapsid (N) encoding genes of SARS-CoV-2 from reported diverse lineages to suggest one-time host jump of a SARS-CoV-2 isolate into the human host. In contrast to human isolates, a high degree of variation in CUP of these genes suggests that bats, pangolins, and dogs are natural reservoi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 41 publications
0
1
0
Order By: Relevance
“…Globally, high risk of reinfection with omicron variant, low vaccine and testing coverage are ideal for mutations resulting in the emergence of new variants of SARS-CoV-2 (Pulliam et al, 2021). Since COVID-19 inception, researchers have been trying to investigate its origin and evolution (Bansal, Kumar, & Patil, 2021; Singh & Soojin, 2021; Tang et al, 2020). We are currently witnessing a global molecular arms race between SARS-CoV-2 and its preventive therapeutics based on diverse regimes such as DNA, RNA, protein or inactivated whole-virion, etc.…”
Section: Introductionmentioning
confidence: 99%
“…Globally, high risk of reinfection with omicron variant, low vaccine and testing coverage are ideal for mutations resulting in the emergence of new variants of SARS-CoV-2 (Pulliam et al, 2021). Since COVID-19 inception, researchers have been trying to investigate its origin and evolution (Bansal, Kumar, & Patil, 2021; Singh & Soojin, 2021; Tang et al, 2020). We are currently witnessing a global molecular arms race between SARS-CoV-2 and its preventive therapeutics based on diverse regimes such as DNA, RNA, protein or inactivated whole-virion, etc.…”
Section: Introductionmentioning
confidence: 99%